The story of Johnson & Johnson
U.S. health-care company; its consumer business was separated as Kenvue in 2023.
Johnson & Johnson. U.S. health-care company; its consumer business was separated as Kenvue in 2023.
23 Jun 2020
Johnson & Johnson, decision overturned by Missouri Court of Appeals, Eastern District. Judgment reversed in part for lack of personal jurisdiction over 17 plaintiffs; punitive damages against J&J set at $715,909,091.
2023
until Aug 2023: Kenvue, part of Johnson & Johnson.
23 Aug 2023: Johnson & Johnson owns a stake in Kenvue. 9.5%, as of 23 Aug 2023.
Johnson & Johnson, involved in Recall of Neutrogena and Aveeno aerosol sunscreens, Recall of one lot of Johnson’s Baby Powder, Ingham v. Johnson & Johnson, the J&J talc bankruptcies, J&J talc settlement proposal, July 2026, LTL Management bankruptcy over talc claims, J&J proposed resolution of ovarian talc litigation and Red River Talc bankruptcy plan.
According to Johnson & Johnson.
Johnson & Johnson disputes a finding of Health Canada finding on talc and ovarian cancer.
According to Johnson & Johnson.
Johnson & Johnson, headquartered in New Jersey.
18 sourced connections, each with its evidence. Open the explorer to follow any of them further, filter by lens, or move through time.
Drawn from the sourced links on Johnson & Johnson. Change a link and this story changes with it.